<?xml version="1.0" encoding="UTF-8"?>
<ref id="B122">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lai</surname>
    <given-names>C.-C.</given-names>
   </name>
   <name>
    <surname>Shih</surname>
    <given-names>T.-P.</given-names>
   </name>
   <name>
    <surname>Ko</surname>
    <given-names>W.-C.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>H.-J.</given-names>
   </name>
   <name>
    <surname>Hsueh</surname>
    <given-names>P.-R.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges.</article-title>
  <source>
   <italic>Int. J. Antimicrob. Agents</italic>
  </source>
  <volume>55</volume>:
  <issue>105924</issue>. 
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id>
  <?supplied-pmid 32081636?>
  <pub-id pub-id-type="pmid">32081636</pub-id>
 </mixed-citation>
</ref>
